GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression

Neuropsychopharmacology

Volumn 32, Issue 2, 2007, Pages 471-482

  Rajkowska, Grazyna ^a,d   O'Dwyer, Gillian ^a   Teleki, Zsofia ^a,b   Stockmeier, Craig A ^a,c   Miguel Hidalgo, Jose Javier ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Dorsolateral prefrontal cortex; Interneurons; Morphometry; Orbitofrontal cortex; Post mortem

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN; CALCIUM BINDING PROTEIN; PARVALBUMIN;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN LEVEL; CELL COUNT; CELL DENSITY; CELL SIZE; CELL SUBPOPULATION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MOLECULAR PROBE; NERVE CELL; NEUROIMAGING; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS; TISSUE SECTION;

EID: 33846251906     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301234     Document Type: Article

References (96)

1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE et al (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52: 258-266.
2. Aznar S, Qian Z, Shah R, Rahbek B, Knudsen GM (2003). The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res 959: 58-67.
3. Baimbridge KG, Celio MR, Rogers JH (1992). Calcium-binding proteins in the nervous system. Trends Neurosci 15: 303-308.
4. Balestrino M, Somjen GG (1988). Concentration of carbon dioxide, interstitial pH and synaptic transmission in hippocampal formation of the rat. J Physiol 396: 247-266.
5. Beasley C, Reynolds G (1997). Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res 24: 349-355.
6. Beasley CL, Zhang ZJ, Patten I, Reynolds GP (2002). Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52: 708-715.
7. Bechara A, Damasio H, Damasio AR (2000). Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10: 295-307.
8. Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA et al (1999). Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 156: 952-954.
9. Benes FM, Berretta S (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25: 1-27.
10. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44: 88-97.
11. Benes FM, Todtenkopf MS, Logiotatos P, Williams M (2000). Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J Chem Neuroanat 20: 259-269.
12. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004a). Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9: 386-392.
13. Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews PM, Cowen PJ (2004b). Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 161: 368-370.
14. Billups B, Attwell D (1996). Modulation of non-vesicular glutamate release by pH. Nature 379: 171-174.
15. Brambilla P, Perez J, Barale F, Schettini G, Soares JC (2003). GABAergic dysfunction in mood disorders. Mol Psychiatry 8: 721-737, 715.
16. Burnet PW, Eastwood SL, Lacey K, Harrison PJ (1995). The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res 676: 157-168.
17. Cadoux-Hudson TA, Wade D, Taylor DJ, Rajagopalan B, Ledingham JG, Briggs M et al (1990). Persistent metabolic sequelae of severe head injury in humans in vivo. Acta Neurochir (Wiener) 104: 1-7.
18. 2 and pH: changes during convulsive activity and their significance for spontaneous arrest of seizures. Epilepsia 13: 699-725.
19. Cauli B, Audinat E, Lambolez B, Angulo MC, Ropert N, Tsuzuki K et al (1997). Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci 17: 3894-3906.
20. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP et al (2005). Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 102: 15653-15658.
21. Conde F, Lund JS, Jacobowitz DM, Baimbridge KG, Lewis DA (1994). Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol 341: 95-116.
22. Constantinidis C, Goldman-Rakic PS (2002). Correlated discharges among putative pyramidal neurons and interneurons in the primate prefrontal cortex. J Neurophysiol 88: 3487-3497.
23. Cotter D, Hudson L, Landau S (2005). Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord 7: 358-369.
24. Cotter D, Landau S, Beasley C, Stevenson R, Chana G, MacMillan L et al (2002a). The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 51: 377-386.
25. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP (2002b). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12: 386-394.
26. Cruz DA, Eggan SM, Lewis DA (2003). Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol 465: 385-400.
27. Cummings JL (1993). Frontal-subcortical circuits and human behavior. Arch Neurol 50: 873-880.
28. Cummings JL (1995). Anatomic and behavioral aspects of frontal-subcortical circuits. Ann NY Acad Sci 769: 1-13.
29. Daviss S, Lewis D (1995). Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 59: 81-96.
30. DeFelipe J (1997). Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 14: 1-19.
31. DeFelipe J, Hendry SH, Jones EG (1989). Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc Natl Acad Sci USA 86: 2093-2097.
32. 2+ extrusion mechanisms in dialyzed squid axons. Biochim Biophys Acta 688: 237-245.
33. Freund TF, Gulyas AI, Acsady L, Gorcs T, Toth K (1990). Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci USA 87: 8501-8505.
34. Gabbott PL, Dickie BG, Vaid RR, Headlam AJ, Bacon SJ (1997). Local-circuit neurones in the medial prefrontal cortex (areas 25, 32 and 24b) in the rat: morphology and quantitative distribution. J Comp Neurol 377: 465-499.
35. Goldman SA, Pulsinelli WA, Clarke WY, Kraig RP, Plum F (1989). The effects of extracellular acidosis on neurons and glia in vitro. J Cereb Blood Flow Metab 9: 471-477.
36. Gruol DL, Barker JL, Huang LY, MacDonald JF, Smith Jr TG (1980). Hydrogen ions have multiple effects on the excitability of cultured mammalian neurons. Brain Res 183: 247-252.
37. Hashimoto T, Lewis DA (2006). BDNF Val66Met polymorphism and GAD67 mRNA expression in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 163: 534-537.
38. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z et al (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23: 6315-6326.
39. Henkel V, Baghai TC, Eser D, Zill P, Mergl R, Zwanzger P et al (2004). The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: a genetic association study. Am J Med Genet B Neuropsychiatr Genet 126: 82-87.
40. Hornung JP (2003). The human raphe nuclei and the serotonergic system. J Chem Neuroanat 26: 331-343.
41. Hornung JP, Celio MR (1992). The selective innervation by serotoninergic axons of calbindin-containing interneurons in the neocortex and hippocampus of the marmoset. J Comp Neurol 320: 457-467.
42. Iritani S, Kuroki N, Ikeda K, Kazamatsuri H (1999). Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 23: 409-421.
43. Jakab RL, Goldman-Rakic PS (2000). Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol 417: 337-348.
44. Kalus P, Senitz D, Beckmann H (1997). Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients. Psychiatry Res 75: 49-59.
45. Karolewicz B, Szebeni K, Stockmeier CA, Konick L, Overholser JC, Jurjus G et al (2004). Low nNOS protein in the locus coeruleus in major depression. J Neurochem 91: 1057-1066.
46. Kawaguchi Y, Kubota Y (1993). Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. J Neurophysiol 70: 387-396.
47. Kawaguchi Y, Kubota Y (1997). GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 7: 476-486.
48. Ke Y, Streeter CC, Nassar LE, Sarid-Segal O, Hennen J, Yurgelun-Todd DA et al (2004). Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 130: 283-293.
49. Kelly TM, Mann JJ (1996). Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand 94: 337-343.
50. Lewis DA, Lund JS (1990). Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor- and parvalbumin-immunoreactive populations. J Comp Neurol 293: 599-615.
51. Lingford-Hughes AR, Acton PD, Gacinovic S, Suckling J, Busatto GF, Boddington SJ et al (1998). Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br J Psychiatry 173: 116-122.
52. Lund JS, Lewis DA (1993). Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J Comp Neurol 328: 282-312.
53. Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO et al (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24: 1478-1485.
54. Miguel-Hidalgo JJ, Dubey P, Shao Q, Stockmeier C, Rajkowska G (2005). Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression. Schizophr Res 76: 159-171.
55. Miguel-Hidalgo JJ, Rajkowska G (1999). Immunohistochemistry of neural markers for the study of the laminar cytoarchitecture in celloidin sections from the human cerebral cortex. J Neurosci Meth 93: 69-79.
56. + channel blockers is mediated by changes in pHi. Neuroreport 6: 193-196.
57. Pazos A, Probst A, Palacios J (1987a). Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21: 97-122.
58. Pazos A, Probst A, Palacios JM (1987b). Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21: 123-139.
59. Petty F (1995). GABA and mood disorders: a brief review and hypothesis. J Affect Disord 34: 275-281.
60. Pierri JN, Chaudry AS, Woo TU, Lewis DA (1999). Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 156: 1709-1719.
61. Rajkowska G (2003). Depression: what we can learn from postmortem studies. The Neuroscientist 9: 273-284.
62. Rajkowska G, Goldman-Rakic PS (1995a). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Quantitative criteria for distinguishing areas 9 and 46. Cereb Cortex 4: 307-322.
63. Rajkowska G, Goldman-Rakic PS (1995b). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46. Cereb Cortex 4: 323-337.
64. Rajkowska G, Miguel-Hidalgo JJ, Dubey P, Stockmeier CA, Krishnan KR (2005). Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry 58: 297-306.
65. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY et al (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45: 1085-1098.
66. Rajkowska G, O'Dwyer G, Shao Q, Stockmeier CA, Miguel-Hidalgo JJ (2002). Calbindin immunoreactive non-pyramidal neurons are reduced in the dorsolateral prefrontal cortex in major depression and schizophrenia. Program No. 49720 2002 Abstract Viewer/Itinerary Planner. Society for Neuroscience: Washington, DC; 2002 CD-ROM.
67. Rao SG, Williams GV, Goldman-Rakic PS (2000). Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20: 485-494.
68. Reynolds GP, Beasley CL (2001). GABAergic neuronal subtypes in the human frontal cortex-development and deficits in schizophrenia. J Chem Neuroanat 22: 95-100.
69. Robello M, Baldelli P, Cupello A (1994). Modulation by extracellular pH of the activity of GABAA receptors on rat cerebellum granule cells. Neuroscience 61: 833-837.
70. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL et al (2004). Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61: 705-713.
71. Sanacora G, Mason GF, Krystal JH (2000). Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol 14: 23-45.
72. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA et al (1999). Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56: 1043-1047.
73. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB et al (2003a). Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160: 577-579.
74. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002). Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159: 663-665.
75. Sanacora G, Rothman DL, Mason G, Krystal JH (2003b). Clinical studies implementing glutamate neurotransmission in mood disorders. Ann NY Acad Sci 1003: 292-308.
76. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J et al (2000). Brain serotonin1 A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57: 174-180.
77. Sawaguchi T, Matsumura M, Kubota K (1989). Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys. Exp Brain Res 75: 457-469.
78. Sen S, Villafuerte S, Nesse R, Stoltenberg SF, Hopcian J, Gleiberman L et al (2004). Serotonin transporter and GABAA alpha 6 receptor variants are associated with neuroticism. Biol Psychiatry 55: 244-249.
79. Sesack SR, Snyder CL, Lewis DA (1995). Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 363: 264-280.
80. Smiley JF, Goldman-Rakic PS (1996). Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy. J Comp Neurol 367: 431-443.
81. Smith ML, von Hanwehr R, Siesjo BK (1986). Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats. J Cereb Blood Flow Metab 6: 574-583.
82. Somogyi P, Tamas G, Lujan R, Buhl EH (1998). Salient features of synaptic organisation in the cerebral cortex. Brain Res Brain Res Rev 26: 113-135.
83. Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY et al (2004). Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 56: 640-650.
84. Takahashi M, Kovalchuk Y, Attwell D (1995). Pre- and postsynaptic determinants of EPSC waveform at cerebellar climbing fiber and parallel fiber to Purkinje cell synapses. J Neurosci 15: 5693-5702.
85. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J et al (2004). Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55: 346-352.
86. Trottier S, Evrard B, Vignal JP, Scarabin JM, Chauvel P (1996). The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res 25: 79-106.
87. Uylings HB, Sanz-Arigita EJ, de Vos K, Pool CW, Zilles K, Rajkowska G (2006). 3-D cytoarchitectonic parcellation of human orbitofrontal cortex. Correlation with postmortem MRI. Eur J Neurosci (under review).
88. Uylings HBM, Delalle I, Petanjek Z, Koenderink MJT (2002). Structural and immunocytochemical differentiation of neurons in prenatal and postnatal human prefrontal cortex. Neuroembryology 1: 176-186.
89. Van Otterloo ES, Miguel-Hidalgo JJ, Stockmeier CA, Rajkowska G (2005). Microglia immunoreactivity is unchanged in the white matter of orbitofrontal cortex in elderly depressed patients. Program No. 9152 2005 Abstract Viewer/Itinerary Planner. Society for Neuroscience: Washington, DC (Online).
90. Varnas K, Halldin C, Hall H (2004). Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22: 246-260.
91. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2000). Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57: 237-245.
92. Volkow ND, Fowler JS (2000). Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10: 318-325.
93. Wilson FAW, Scalaidhe SPO, Goldman-Rakic PS (1994). Functional synergism between putative a-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex. Proc Natl Acad Sci 91: 4009-4013.
94. Woo TU, Miller JL, Lewis DA (1997). Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry 154: 1013-1015.
95. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA (1998). A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95: 5341-5346.
96. Zaitsev AV, Gonzalez-Burgos G, Povysheva NV, Kroner S, Lewis DA, Krimer LS (2005). Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex 15: 1178-1186.